Cleared Traditional

K921669 - MARQUETTE SL SERIES TRANSPORT REMOTE ACQUISITION (FDA 510(k) Clearance)

K921669 · Marquette Electronics, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1993
Decision
394d
Days
-
Risk

K921669 is an FDA 510(k) clearance for the MARQUETTE SL SERIES TRANSPORT REMOTE ACQUISITION.

Submitted by Marquette Electronics, Inc. (Milwaukee, US). The FDA issued a Cleared decision on May 7, 1993 after a review of 394 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Marquette Electronics, Inc. devices

Submission Details

510(k) Number K921669 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 1992
Decision Date May 07, 1993
Days to Decision 394 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
269d slower than avg
Panel avg: 125d · This submission: 394d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LOS
Device Class -